Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p/STAT3 axis in breast cancer

127Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

To explore the effect of circRHOT1 on breast cancer progression and the underlying mechanism. Significantly, our data revealed that the depletion of circRHOTI was able to repress the proliferation and induce the apoptosis of breast cancer cells. CircRHOTI knockdown could remarkably inhibit the invasion and migration in the breast cancer cells. Meanwhile, the depletion of circRHOTI enhanced the erastin-induced inhibition effect on cell growth of breast cancer cells. The circRHOT1 knockdown notably increased the levels of reactive oxygen species (ROS), iron, and Fe2+ in breast cancer cells. Mechanically, circRHOTI was able to sponge microRNA-106a-5p (miR-106a-5p) and inhibited ferroptosis by down-regulating miR-106a-5p in breast cancer cells. Besides, miR-106a-5p induced ferroptosis by targeting signal transducer and activator of transcription 3 (STAT3) in the system. Moreover, the overexpression of STAT3 and miR-106a-5p inhibitor could reverse circRHOTI knockdown-mediated breast cancer progression. Functionally, circRHOTI promoted the tumor growth of breast cancer in vivo. In conclusion, we discovered that circRHOTI contributed to malignant progression and attenuated ferroptosis in breast cancer by the miR-106a-5p/STAT3 axis. Our finding provides new insights into the mechanism by which circRHOTI promotes the development of breast cancer. CircRHOTI and miR-106a-5p may serve as potential targets for breast cancer therapy.

Cite

CITATION STYLE

APA

Zhang, H., Ge, Z., Wang, Z., Gao, Y., Wang, Y., & Qu, X. (2021). Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p/STAT3 axis in breast cancer. Aging, 13(6), 8115–8126. https://doi.org/10.18632/aging.202608

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free